The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-cell multiomics analysis of IRF4 in mediating treatment resistance in ibrutinib-treated chronic lymphocytic leukemia (CLL).
 
Alina S. Gerrie
Honoraria - Abbvie; AstraZeneca; BeiGene; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Janssen (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Janssen
 
Gerben Duns
No Relationships to Disclose
 
Yifan Yin
No Relationships to Disclose
 
Shinya Rai
No Relationships to Disclose
 
Laura Hilton
No Relationships to Disclose
 
Barbara Meissner
No Relationships to Disclose
 
Hisae Nakamura
No Relationships to Disclose
 
Luke O'Brien
No Relationships to Disclose
 
Merrill Boyle
No Relationships to Disclose
 
Ryan Morin
No Relationships to Disclose
 
Aaron Marshall
No Relationships to Disclose
 
Spencer B. Gibson
No Relationships to Disclose
 
David W. Scott
Consulting or Advisory Role - Abbvie; AstraZeneca; Incyte; Janssen
Research Funding - Janssen; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Named inventor on a patent on the use of gene expression profiling to assign cell-of-origin in diffuse large B-cell lymphoma.; Named inventor on a pending patent describing gene expression profiling in prognostication in classical Hodgkin lymphoma.; Named inventor on a pending patent describing using gene expression profiling to identify molecular subtypes of GCB-DLBCL.; Named inventor on a pending patent on the use of gene expression profiling to determine the proliferation signature in mantle cell lymphoma.
 
James B. Johnston
No Relationships to Disclose
 
Christian Steidl
Consulting or Advisory Role - Bayer
Research Funding - Epizyme (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Holder of a patent "Method for Determining Lymphoma Type" using the Nanostring platform
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Eisai